Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
about
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsCS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activityInefficient transmission of H5N1 influenza viruses in a ferret contact modelGlobal alert to avian influenza virus infection: from H5N1 to H7N9Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B VirusesA Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B VirusesSerendipitous discovery of a potent influenza virus a neuraminidase inhibitorInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceResource competition may lead to effective treatment of antibiotic resistant infectionsAntiviral therapy of influenza.Influenza: lessons from past pandemics, warnings from current incidents.In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase.Extreme evolutionary conservation of functionally important regions in H1N1 influenza proteome.Continuing challenges in influenza.Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.Genomic reassortants of pandemic A (H1N1) 2009 virus and endemic porcine H1 and H3 viruses in swine in Japan.Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidaseRapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.Pandemic Seasonal H1N1 Reassortants Recovered from Patient Material Display a Phenotype Similar to That of the Seasonal Parent.OpenFluDB, a database for human and animal influenza virus.Influenza A Virus in Backyard Pigs and Poultry in Rural Cambodia.Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitorsDetection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birdsComputer-based de novo designs of tripeptides as novel neuraminidase inhibitors.Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis.Rethinking approaches to improve the utilization of nucleic acid amplification tests for detection and characterization of influenza A in diagnostic and reference laboratories.Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicComparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.Isolation of highly pathogenic avian influenza H5N1 virus from Saker falcons (Falco cherrug) in the Middle EastLaninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.A molecular and antigenic survey of H5N1 highly pathogenic avian influenza virus isolates from smallholder duck farms in Central Java, Indonesia during 2007-2008.Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteinsEvolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009.
P2860
Q22305941-8A87C916-09A0-4CF5-B99C-0DF77A547E0BQ24655526-5034B116-69C9-4ADF-A62C-AF25C951CBBAQ24684249-DBAFFB5F-C00C-4A61-A878-62482F8F1A80Q26864488-D986D318-6540-485C-A902-234642B37A54Q27663966-94583C25-2707-4DC8-B914-A4053F5C5633Q27683640-F3FE5A58-EED1-421B-ADC3-D7DC8039C6C6Q27687973-B897D80B-78CE-4671-A6AB-14DE1021BEE3Q28282405-603DAC8F-1874-447E-8205-D7BCB012D906Q28537662-418DF080-83DE-4124-9603-9F42AD050CB0Q30350565-2B8738AB-C4C5-4A1A-8DA0-6075D1FC12A7Q30351160-81728BF0-0446-40A4-BE2B-BE99F4AD38EAQ30353814-3616314C-6BB1-423E-A6D8-CD54DC7C59A8Q30356104-FF233ACD-1F92-40A0-BDA6-A73322FD16CDQ30363190-B84DC2A6-5F22-4688-824C-00C5F27F0FD7Q30364619-EFB0C283-07B1-489C-8A50-D61A92472D6FQ30365051-EDB740A8-54C9-40F1-B4AD-86E1917F46B6Q30378860-2274F1B3-1344-4E25-85A2-EBDC7B3D272FQ30385853-5344B424-969F-4FC0-ADED-E46B9E4F18DBQ30386535-8A1F68CC-3D1F-40E8-804B-88C5E661C882Q30389102-9E36E073-119B-404E-A3E8-2AC92C2DDF3EQ30391319-5F675D42-9760-4E63-A767-F6D33BE74A24Q30391358-05BA6C16-849E-49C0-B04D-AFFF0E6654D4Q30397253-3CC5AD98-8633-40D7-8CD7-BB2C63C5F9CAQ30398804-5B86157D-6BBC-4549-B078-290E0A40F96BQ30403144-DE1377F8-E52B-427F-BCFC-A7D6FC1D936CQ30404038-ABD3F26F-857D-4159-A86E-4FA1D58A7D00Q30409553-3C237F6A-7442-4638-A125-372FA528A806Q30410029-A001978C-4B8B-4B5F-8B48-7320C4E6D245Q30415228-887638FD-47A7-4EE4-82E0-8588CB09D1B6Q30419391-82FC274A-0A0A-4E0F-93F2-39D3C9BE3342Q30438502-37C19C18-F2DA-4E59-BF30-E409E9EB07C4Q30445738-8FCA5E4C-1791-4615-98B4-3FCBE674C5C6Q33635627-754FA1FE-8480-4429-A421-D92A048D6D47Q33676271-9380AB8B-9777-4726-83C8-574F6E547C2AQ34012407-E98BB3BB-BE46-4D32-BC3E-8492488D7512Q34057596-22583B6E-5D58-43F1-BE0A-3192FAE335C8Q34253111-F76EB50B-D9B7-46BA-A27B-E612C2B8531CQ34597005-1E631836-E20D-4306-9DAF-0319F7682B20Q34648838-53100334-1519-47AC-8811-B7D80865D443Q34695284-B5C79FC2-7E10-47CD-8094-5C03BECF0D4B
P2860
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@ast
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@en
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@nl
type
label
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@ast
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@en
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@nl
prefLabel
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@ast
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@en
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@nl
P3181
P1433
P1476
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
@en
P2093
Larisa V Gubareva
P304
P3181
P356
10.1016/J.VIRUSRES.2004.02.034
10.1016/S0168-1702(04)00133-9
P407
P577
2004-07-01T00:00:00Z